Mediwound Net Interest Income Over Time
| MDWD Stock | USD 17.26 0.01 0.06% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Mediwound Performance and Mediwound Correlation. Mediwound | Build AI portfolio with Mediwound Stock |
Will Pharmaceuticals sector continue expanding? Could Mediwound diversify its offerings? Factors like these will boost the valuation of Mediwound. Expected growth trajectory for Mediwound significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Mediwound data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.84) | Revenue Per Share | Quarterly Revenue Growth 0.247 | Return On Assets | Return On Equity |
Investors evaluate Mediwound using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Mediwound's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Mediwound's market price to deviate significantly from intrinsic value.
Understanding that Mediwound's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mediwound represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Mediwound's market price signifies the transaction level at which participants voluntarily complete trades.
Cross Equities Net Interest Income Analysis
Compare Mediwound and related stocks such as Eupraxia Pharmaceuticals, NeOnc Technologies, and Genfit SA Net Interest Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPRX | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (965.4 K) | (551.1 K) | (307.2 K) | 556.4 K | 639.8 K | 671.8 K |
| NTHI | (112.9 K) | (112.9 K) | (112.9 K) | (112.9 K) | (112.9 K) | (112.9 K) | (112.9 K) | (112.9 K) | (112.9 K) | (112.9 K) | (112.9 K) | (112.9 K) | (200.2 K) | (2.7 M) | (2.7 M) | (2.4 M) | (2.3 M) |
| GNFT | 427 K | 427 K | 427 K | 427 K | 427 K | 427 K | 427 K | (820 K) | (10.4 M) | (8.5 M) | (18.8 M) | 37.7 M | 3.5 M | (1.4 M) | (2.2 M) | (2.5 M) | (2.4 M) |
| SLS | (3.5 M) | (3.5 M) | (3.5 M) | (3.5 M) | (3.5 M) | (3.5 M) | (3.5 M) | (462 K) | (266 K) | 118 K | 26 K | 6 K | 317 K | 642 K | 632 K | 726.8 K | 763.1 K |
| TARA | 466 K | 466 K | 466 K | 466 K | 466 K | 466 K | 466 K | 466 K | 466 K | 466 K | 466 K | 237 K | 1.1 M | 2.9 M | 4.1 M | 4.8 M | 5 M |
| OBIO | 331 K | 331 K | 331 K | 331 K | 331 K | 331 K | 331 K | 331 K | 331 K | 331 K | 331 K | (927 K) | 50 K | 3.8 M | 3.4 M | 3.9 M | 4.1 M |
| RNAC | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.2 M) | (1.5 M) | (1.5 M) | (1.6 M) | (2.8 M) | (3 M) | (2.8 M) | 7.4 M | 8.5 M | 8.9 M |
| AARD | 120 K | 120 K | 120 K | 120 K | 120 K | 120 K | 120 K | 120 K | 120 K | 120 K | 120 K | 120 K | 120 K | 1.4 M | 2.4 M | 2.8 M | 1.5 M |
| IVA | 488.7 K | 488.7 K | 488.7 K | 488.7 K | 488.7 K | 488.7 K | 488.7 K | 270.7 K | (97 K) | 138 K | (3.9 M) | (86 K) | 2.8 M | (4.2 M) | (11.1 M) | (10 M) | (9.5 M) |
Mediwound and related stocks such as Eupraxia Pharmaceuticals, NeOnc Technologies, and Genfit SA Net Interest Income description
The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.My Equities
My Current Equities and Potential Positions
| Mediwound | MDWD |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 42 Hayarkon Street, |
| Exchange | NASDAQ Exchange |
USD 17.26
Check out Mediwound Performance and Mediwound Correlation. For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Mediwound technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.